Isentio has merged with Pathogenomix, Inc.
Isentio RIPSEQ is an online application that dramatically improves the bacteria identification process. A must for samples affected by Antibiotics and for Anaerobe Infections.
Isentio was founded in 2005 and is based on research done on advanced DNA analysis methods by the three founders, Oyvind Kommedal, Oystein Saebo and Bjarte Karlsen. The resulting product, RipSeq(R), is an online software tool for rapid bacterial identification, with focus on analyzing mixed clinical samples. This unique method can reduce the bacterial identification time with up to 90% as well as provide answers where ALL other methods fail or are inadequate.
The company’s objective is to expand the RipSeq product line to become the leading DNA analysis tool for pathogen identification worldwide.
Company Details
- Founded
- -
- Address
- 2600 El Camino Real,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Palo Alto, California
Isentio Questions
Isentio's website is https://www.linkedin.com/company/pathogenomix-inc
Isentio's LinkedIn profile is https://www.linkedin.com/company/isentio-as
Isentio's industry is
Biotechnology Research
Isentio's top competitors are
Luminex,
Stuns Life Science,
Tdb Labs Ab,
Gyros Protein Technologies,
Immuneed,
Genetic Analysis As,
2curex - Individualizing Cancer Treatment,
Elect Bioscience Ab.
Isentio's categories are Biotechnology Research
Isentio's founding year is 2005
